Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.

Trial Profile

Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Mar 2012 Planned patient number is 15, actual initiation date (Dec 2009) added and additional lead trial investigator (Dr Concepta Merry) identified as reported by Pan-African Clinical Trials Registry record.
    • 14 Mar 2012 Planned end date (Feb 2010) added as reported by Pan-African Clinical Trials Registry record.
    • 17 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top